Mario Gabelli Biomarin Pharmaceutical Inc Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 6,565 shares of BMRN stock, worth $416,352. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,565

Previous 5,315 23.52%

Holding current value

$416,352

Previous $437,000 5.49%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $86,275 - $117,300	1,250 Added 23.52%	6,565 $461,000
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $395,595 - $490,149	5,315 New	5,315 $437,000
Q3 2023 Nov 08, 2023	SELL	$85.07 - $94.48 $39,982 - $44,405	-470 Reduced 14.76%	2,714 $240,000
Q2 2023 Aug 10, 2023	SELL	$86.68 - $100.3 $31,204 - $36,108	-360 Reduced 10.16%	3,184 $275,000
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $25,444 - $34,008	290 Added 8.91%	3,544 $344,000
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $19,665 - $26,397	-243 Reduced 6.95%	3,254 $336,000
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $7,805 - $9,209	95 Added 2.79%	3,497 $296,000
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $47,176 - $57,320	-660 Reduced 16.25%	3,402 $282,000
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $52,218 - $65,161	-703 Reduced 14.75%	4,062 $313,000
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $405,433 - $517,079	-5,653 Reduced 54.26%	4,765 $421,000
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $28,861 - $32,991	-386 Reduced 3.57%	10,418 $805,000
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $2,265 - $2,543	30 Added 0.28%	10,804 $901,000
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $486,043 - $589,847	6,504 Added 152.32%	10,774 $814,000
Q4 2020 Feb 05, 2021	BUY	$72.61 - $90.2 $310,044 - $385,154	4,270 New	4,270 $374,000
Q2 2019 Aug 02, 2019	SELL	$80.35 - $93.9 $184,805 - $215,970	-2,300 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$84.2 - $98.62 $193,660 - $226,826	2,300 New	2,300 $204,000
Q4 2018 Jan 30, 2019	SELL	$80.14 - $106.07 $184,322 - $243,960	-2,300 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$76.01 - $99.03 $22,803 - $29,709	-300 Reduced 11.54%	2,300 $217,000
Q4 2017 Feb 02, 2018	BUY	$80.76 - $95.13 $209,976 - $247,338	2,600	2,600 $232,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account